Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: CARBOPLATIN, . Treffer: 41

2022

Grümme, L; Biewald, E; Reschke, M; Fischhuber, K; Hanbücken, A; Schlüter, S; Müller, B; Kiefer, T; Göricke, S; Geismar, D; Ryl, T; Sirin, S; Wieland, R; Timmermann, B; Lohmann, D; Ebinger, M; Brecht, IB; Schönberger, S; Schwab, C; Eggert, A; Süsskind, D; Ritter-Sovinz, P; Bechrakis, NE; Ketteler, P Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma.
Pediatr Blood Cancer. 2022; 69(2):e29362 Doi: 10.1002/pbc.29362 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Moritz, J; Bauernhofer, T; Mannweiler, S; Langsenlehner, T; Pummer, K; Dandachi, N; Pichler, M Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients.
In Vivo. 2020; 34(6): 3631-3638. Doi: 10.21873/invivo.12209 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Koch, OO; Weitzendorfer, M; Varga, M; Tschoner, A; Partl, R; Perathoner, A; Gehwolf, P; Kapp, KS; Függer, R; Öfner, D; Emmanuel, K Perioperative chemotherapy versus neoadjuvant chemoradiation for patients with adenocarcinoma of the distal esophagus in Austria: a retrospective analysis.
World J Surg Oncol. 2019; 17(1): 146-146. Doi: 10.1186/s12957-019-1693-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
BMC CANCER. 2018; 18(1): 1074-1074. Doi: 10.1186/s12885-018-4979-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408 Doi: 10.1007/s12094-017-1742-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Hoeppner, J; Lordick, F; Brunner, T; Glatz, T; Bronsert, P; Röthling, N; Schmoor, C; Lorenz, D; Ell, C; Hopt, UT; Siewert, JR ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).
BMC Cancer. 2016; 16:503 Doi: 10.1186/s12885-016-2564-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sehouli, J; Chekerov, R; Reinthaller, A; Richter, R; Gonzalez-Martin, A; Harter, P; Woopen, H; Petru, E; Hanker, LC; Keil, E; Wimberger, P; Klare, P; Kurzeder, C; Hilpert, F; Belau, AK; Zeimet, A; Bover-Barcelo, I; Canzler, U; Mahner, S; Meier, W Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).
Ann Oncol. 2016; 27(12):2236-2241 Doi: 10.1093/annonc/mdw418 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Volgger, B; Zeimet, AG; Reinthaller, A; Petru, E; Schauer, C; Klein, M; Sevelda-Schwarzgruber, U; Bogner, G; Wolfram, G; Marth, C Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria.
Int J Gynecol Cancer. 2015; 25(2):257-262 Doi: 10.1097/IGC.0000000000000352 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Stampfl, U; Bermejo, JL; Sommer, CM; Hoffmann, K; Weiss, KH; Schirmacher, P; Schemmer, P; Kauczor, HU; Richter, GM; Radeleff, BA; Longerich, T Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study.
J Vasc Interv Radiol. 2014; 25(7):1018-1026 Doi: 10.1016/j.jvir.2014.03.007
Web of Science PubMed FullText FullText_MUG

 

2012

Henzler, T; Konstandin, S; Schmid-Bindert, G; Apfaltrer, P; Haneder, S; Wenz, F; Schad, L; Manegold, C; Schoenberg, SO; Fink, C Imaging of tumor viability in lung cancer: initial results using 23Na-MRI.
Rofo. 2012; 184(4):340-344 Doi: 10.1055/s-0031-1299277
Web of Science PubMed FullText FullText_MUG

 

2011

Kurtz, JE; Kaminsky, MC; Floquet, A; Veillard, AS; Kimmig, R; Dorum, A; Elit, L; Buck, M; Petru, E; Reed, N; Scambia, G; Varsellona, N; Brown, C; Pujade-Lauraine, E; on behalf of Gynecologic Cancer Intergroup Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.
ANN ONCOL. 2011; 22(11): 2417-2423. Doi: 10.1093/annonc/mdr001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2010

Petru, E; Reinthaller, A; Angleitner-Boubenizek, L; Schauer, C; Zeimet, A; Dirschlmayer, W; Medl, M; Stummvoll, W; Sevelda, P; Marth, C Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: results of an Austrian gynecologic oncologists' expert meeting.
WIEN KLIN WOCHENSCHR. 2010; 122(21-22): 649-652. Doi: 10.1007/s00508-010-1483-1
Web of Science PubMed FullText FullText_MUG

 

Tomuleasa, C; Soritau, O; Rus-Ciuca, D; Pop, T; Todea, D; Mosteanu, O; Pintea, B; Foris, V; Susman, S; Kacsó, G; Irimie, A Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
J Gastrointestin Liver Dis. 2010; 19(1):61-67 [OPEN ACCESS]
Web of Science PubMed

 

2008

Leyvraz, S; Pampallona, S; Martinelli, G; Ploner, F; Perey, L; Aversa, S; Peters, S; Brunsvig, P; Montes, A; Lange, A; Yilmaz, U; Rosti, G; Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
J Natl Cancer Inst. 2008; 100(8): 533-541. Doi: 10.1093/jnci/djn088 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Petru, E; Andel, J; Angleitner-Boubenizek, L; Steger, G; Bernhart, M; Busch, K; Gehmacher, O; Hernler, T; Kastner, U; Lanz-Veit, A; Pluschnigg, U; Polachova, J; Rohde, M; Schiller, L; Schramböck, R; Stangl, W; Thödtmann, R; Zabernigg, A Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy.
Wien Med Wochenschr. 2008; 158(5-6): 169-173. Doi: 10.1007/s10354-008-0515-1
PubMed FullText FullText_MUG Google Scholar

 

2007

Hilpert, F; du Bois, A; Greimel, E; Hedderich, J; Krause, G; Venhoff, L; Loibl, S; Pfisterer, J Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany.
Ann Oncol. 2007; 18(2): 282-287. Doi: 10.1093/annonc/mdl401 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Huber, J; Sovinz, P; Lackner, H; Mokry, M; Eder, H; Urban, C Diencephalic syndrome: a frequently delayed diagnosis in failure to thrive.
Klin Padiatr. 2007; 219(2): 91-94. Doi: 10.1055/s-2007-921559 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Klaritsch, P; Reich, O; Regauer, S; Bauernhofer, T Recurrent endometrial stromal sarcoma after treatment with high-dose chemotherapy and autologous stem-cell support: A case report.
Eur J Gynaecol Oncol. 2006; 27(3):297-298 (- Case Report)
Web of Science PubMed

 

Marth, C; Windbichler, GH; Hausmaninger, H; Petru, E; Estermann, K; Pelzer, A; Mueller-Holzner, E Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study.
Int J Gynecol Cancer. 2006; 16(4): 1522-1528. Doi: 10.1111/j.1525-1438.2006.00622.x
Web of Science PubMed FullText FullText_MUG

 

Peintinger, F; Georgoulopoulos, A; Ralph, G; Piswanger, C Retrospective comparison of chemotherapy-induced myelotoxicity in patients with ovarian cancer under and over 60 years of age.
J Chemother. 2006; 18(6): 656-661. Doi: 10.1179/joc.2006.18.6.656
Web of Science PubMed FullText FullText_MUG

 

2005

Richtig, E; Ludwig, R; Kerl, H; Smolle, J Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma.
BRIT J DERMATOL. 2005; 153(5): 925-931. Doi: 10.1111/j.1365-2133.2005.06796.x
Web of Science PubMed FullText FullText_MUG

 

2003

Richtig, E; Hoff, M; Rehak, P; Kapp, K; Hofmann-Wellenhof, R; Zalaudek, I; Poschauko, J; Uggowitzer, M; Kohek, P; Smolle, J Efficacy of superficial and deep regional hyperthermia combined with systemic chemotherapy and radiotherapy in metastatic melanoma.
J Dtsch Dermatol Ges. 2003; 1(8):635-642 Doi: 10.1046/j.1610-0387.2003.03719.x
PubMed FullText FullText_MUG Google Scholar

 

Zimpfer-Rechner, C; Hofmann, U; Figl, R; Becker, JC; Trefzer, U; Keller, I; Hauschild, A; Schadendorf, D Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: a multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG).
Melanoma Res. 2003; 13(5):531-536 Doi: 10.1097/01.cmr.0000056274.56735.c6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Peters-Engl, C; Medl, M; Denison, U; Sevelda, P; Leodolter, S; Petru, E Does long-term application of granulocyte colony-stimulating factor adversely influence overall survival in patients with ovarian cancer? A clinical study.
ANTICANCER RES. 2002; 21(5): 3701-3706.
Web of Science PubMed

 

Quasthoff, S; Hartung, HP Chemotherapy-induced peripheral neuropathy.
J NEUROL 2002 249: 9-17. Doi: 10.1007/PL00007853
Web of Science PubMed FullText FullText_MUG

 

2001

Benesch, M; Lackner, H; Moser, A; Kerbl, R; Schwinger, W; Oberbauer, R; Eder, HG; Mayer, R; Wiegele, K; Urban, C Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas.
Pediatr Neurosurg. 2001; 35(4):173-180 Doi: 10.1159%2F000050418
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Reles, A; Wen, WH; Schmider, A; Gee, C; Runnebaum, IB; Kilian, U; Jones, LA; El-Naggar, A; Minguillon, C; Schönborn, I; Reich, O; Kreienberg, R; Lichtenegger, W; Press, MF Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.
Clin Cancer Res. 2001; 7(10):2984-2997 [OPEN ACCESS]
Web of Science PubMed FullText

 

Scholz, HS; Lax, S; Tamussino, KF; Benedicic, C; Petru, E Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass.
ANTICANCER RES. 2001; 20(6C): 4801-4802. (- Case Report)
Web of Science PubMed

 

2000

Greinix, HT; Linkesch, W; Seifert, M; Kubista, E; Czerwenka, K; Elahi, F; Zielinski, C; Hoecker, P; Steger, G; Schulenburg, A; Neumeister, G; Rabitsch, W; Jakesz, R; Kalhs, P Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients.
Acta Oncol. 2000; 39(1):47-52 Doi: 10.1080/028418600430969
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Bauernhofer, T; Stöger, H; Kasparek, AK; Ploner, F; Kuss, I; Pieber, TR; Kotz, R; Samonigg, H Combined treatment of metastatic osteosarcoma of the spine.
Oncology. 1999; 57(4):265-268 Doi: 10.1159/000012058 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Kümmerer, K; Helmers, E; Hubner, P; Mascart, G; Milandri, M; Reinthaler, F; Zwakenberg, M European hospitals as a source for platinum in the environment in comparison with other sources.
Sci Total Environ. 1999; 225(1-2):155-165 Doi: 10.1016/S0048-9697(98)00341-6
Web of Science PubMed FullText FullText_MUG

 

Lahousen, M; Haas, J; Pickel, H; Hackl, A; Kurz, C; Ogris, H; Stummvoll, W; Winter, R Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomized, prospective, multicenter trial.
Gynecol Oncol. 1999; 73(2):196-201 Doi: 10.1006/gyno.1999.5343
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Pickel, H; Lahousen, M; Petru, E; Stettner, H; Hackl, A; Kapp, K; Winter, R Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer.
Gynecol Oncol. 1999; 72(2):215-219 Doi: 10.1006/gyno.1998.5184
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1998

Hofstra, LS; Kristensen, GB; Willemse, PH; Vindevoghel, A; Meden, H; Lahousen, M; Oberling, F; Sorbe, B; Crump, M; Sklenar, I; Sluiter, WJ; Kiese, B; Trope, CG; de Vries, EG Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma.
J Clin Oncol. 1998; 16(10):3335-3344 Doi: 10.1200/JCO.1998.16.10.3335 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Urban, C; Benesch, M; Pakisch, B; Lackner, H; Kerbl, R; Schwinger, W; Oberbauer, R Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
J Neurooncol. 1998; 39(1):71-80 Doi: 10.1023%2FA%3A1005966407408
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1996

Beyer, J; Kramar, A; Mandanas, R; Linkesch, W; Greinix, A; Droz, JP; Pico, JL; Diehl, A; Bokemeyer, C; Schmoll, HJ; Nichols, CR; Einhorn, LH; Siegert, W High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
J Clin Oncol. 1996; 14(10):2638-2645 Doi: 10.1200/JCO.1996.14.10.2638 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1995

Zoubek, A; Kajtar, P; Flucher-Wolfram, B; Holzinger, B; Mostbeck, G; Thun-Hohenstein, L; Fink, FM; Urban, C; Mutz, I; Schuler, D Response of untreated stage IV Wilms' tumor to single dose carboplatin assessed by up front window therapy.
Med Pediatr Oncol. 1995; 25(1):8-11 Doi: 10.1002/mpo.2950250103
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1992

Petru, E; Pickel, H; Heydarfadai, M; Lahousen, M Remission induction with carboplatin-epirubicin-prednimustine followed by consolidation radiotherapy in advanced ovarian cancer.
INT J CLIN PHARM RES. 1992; 12(4): 205-207.
Web of Science PubMed Google Scholar

 

1991

Pickel, H; Petru, E; Lahousen, M; Stettner, H; Heydarfadai, M; Arian-Schad, K; Hackl, A Consolidation radiotherapy following carboplatin-based chemotherapy in radically operated advanced ovarian cancer. A pilot study.
Am J Clin Oncol. 1991; 14(3):184-187 Doi: 10.1097/00000421-199106000-00002
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1990

Lahousen, M; Haas, J Adjuvant chemotherapy in radical surgery of cervix cancer
ZBL GYNAKOL. 1990; 112(11): 707-713.
Web of Science PubMed

 

1989

Pickel, H; Petru, E; Lahousen, M; Stettner, H; Lehnert, M Efficacy of adjuvant carboplatin-epirubicin chemotherapy in advanced ovarian cancer after radical surgery.
Oncology. 1989; 46(4):222-225 Doi: 10.1159/000226720
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum